Literature DB >> 3789572

Succinylcholine-induced hyperkalemia complicating the neuroleptic malignant syndrome.

A L George, C A Wood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3789572     DOI: 10.7326/0003-4819-106-1-172_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

Review 1.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

2.  Neuroleptic malignant syndrome: a case for electroconvulsive therapy.

Authors:  C C Harland; M M O'Leary; R Winters; J Owens; B Hayes; V Melikian
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

3.  Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?

Authors:  D Kelly; S J Brull
Journal:  Can J Anaesth       Date:  1994-09       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.